Defence is the Best Attack: Immuno-Oncology Breakthroughs

Barcelona, Spain : 11 - 13 May 2027

Scientific Programme

Tuesday 11th May 2027

11:30

Registration

12:00

WELCOME LUNCH

13:00

Conference Welcome - Scientific Programme Committee

Session 1: T cell-based therapies

Chair - Joan Seoane

13:10

Marcela Maus Harvard Medical School, USA

'New findings in CAR-T cells'

Q&A: 13:30-13:40

13:40

Joan Seoane VHIO, Spain

'Enabling T cell engagers in solid tumors'

Q&A: 14:00-14:10

14:10

KEYNOTE LECTURE

Carl June University of Pennsylvania, USA

'CAR T on the Attack Against Cancer'

Q&A: 14:40-14:55

14:55

COFFEE BREAK & SOLO TRAVELLERS MEET UP

15:25

Session 2: Reprogramming Tumor Immunity: Plasticity in the Tumor Microenvironment

Chair - Alena Gros

15:25

SATELLITE SYMPOSIUM

15:55

Anna Obenauf IMP, Austria

'Unlocking immunity: Decoding and reprogramming the immune-evasive tumor microenvironment'

Q&A: 16:15-`16:25

16:25

Leila Akkari NKI, Netherlands

'Leveraging Myeloid Cell Diversity in Cancer- A Matter of Plasticity and Metabolism'

Q&A: 16:45-16:55

16:55

5 SELECTED PROFFERED PAPERS

10 minute presentations

17:55

Welcome Reception

18:45

POSTER DISCUSSION SESSION 1

Wednesday 12th May 2027

08:30

Session 3: Engineering Anti-Tumour Immunity

Chair - Leila Akkari

5 SELECTED PROFFERED PAPERS

10 minute presentations

09:30

Alena Gros VHIO, Spain

'From Tumor Antigens to Personalized T Cell Therapies'

Q&A: 9:50-10:00

10:00

Ton Schumacher NKI, Netherlands

'T cell recognition of human cancer: Cracking the code'

Q&A: 10:20-10:30

10:30

Christoph Scheiermann LMU Munich, Germany and the University of Geneva, Switzerland

'Circadian tumor immune responses'

Q&A: 10:50-11:00

11:00

COFFEE BREAK

11:30

SATELLITE SYMPOSIUM

12:00

5 SELECTED PROFFERED PAPERS

10 minute presentations

13:00

LUNCH

14:00

Session 4: Predicting and Overcoming Immunotherapy Resistance

Chair - Marcela Maus

14:00

Marleen Kok NKI, Netherlands

'Tumor micro-environment dynamcis in immunotherapy response in breast cancer'

Q&A: 14:20-14:30

14:30

Lilian Su Princess Margaret Cancer Centre and University of Toronto, Canada

'Predicting Immune Response and Resistance Beyond Genomics'

Q&A: 14:50-15:00

15:00

Marion Subklewe LMU Klinikum, Germany

'Hematotoxicity as a Driver of Non-Relapse Mortality after CAR T-cell Therapy'

Q&A: 15:20-15:30

15:30

COFFEE BREAK

16:00

NETWORKING SESSION

16:45

5 SELECTED PROFFERED PAPERS

10 minute presentations

17:45

POSTER DISCUSSION SESSION 2

Coffee available

20:30

CONFERENCE DINNER

Optional ticketed event

Thursday 13th May 2027

08:30

Session 5: Cancer Prevention and Early Immune Interception

Chair - Joan Seoane

5 SELECTED PROFFERED PAPERS

10 minute presentations

09:30

Direna Alonso-Curbelo IRB Barcelona, Spain

Q&A: 9:50-10:00

10:00

Charles Swanton The Francis Crick Institute, UK

'Towards Lung Cancer Prevention'

Q&A: 10:20-10:30

10:30

Christoph Bock CeMM Research Centre for Molecular Medicine and Medical University of Vienna, Austria

'Programmed Cells? Epigenetics, AI, and Cell Engineering for Cancer and Immunity'

Q&A: 10:50-11:00

11:00

COFFEE BREAK

11:30

KEYNOTE LECTURE

Miriam Merad Icahn School of Medicine at Mount Sinai, USA

'Targeting myeloid inflammation to prevent lung cancer'

Q&A: 12:00-12:15

12:15

CLOSING SUMMARY AND PRESENTATION OF AWARDS

12:15

DEPART

X [close tab]